
Results 1 - 20 of 1,236 in Irritable Bowel Syndrome
Sucampo reports study data for lubiprostone at GASTRO 2009 UEGF/WCOG
The data presented reflect additional analyses of already disclosed Phase II and Phase III clinical trials of lubiprostone in patients with chronic idiopathic constipation and in patients diagnosed with or reporting irritable bowel syndrome with constipation . Comment?
... of the disease. Find out if these anti-cancer foods really work. More Though stress does not cause irritable bowel syndrome, it can trigger or intensify your symptoms. Learn more to help manage your IBS. More Site Map Comment?
Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting
... in patients with chronic idiopathic constipation (CIC) and in patients diagnosed with or reporting irritable bowel syndrome with constipation (IBS-C). Overall, the data analyses demonstrated that, in these trials, lubiprostone achieved a ... Comment?
Toyota To Replace Accelerator Pedals On 3.8 Million Recalled Vehicles
Toyota to replace accelerator pedals on 3.8 million recalled vehicles. Comment?
A guide for women's health
w/Photo
... issues which might range from minor to serious. It could be as a result of lactose intolerance or irritable bowel syndrome. It could also signal something more serious like colon cancer, ovarian cancer or inflammatory bowel disease. X-rays of the ... Comment?
ALISO VIEJO, Calif. A division of Valeant Pharmaceuticals has launched an authorized generic of an irritable bowel syndrome treatment. Comment?
Oceanside launches generic Librax
ALISO VIEJO,A Calif. A division of Valeant Pharmaceuticals has launched an authorized generic of an irritable bowel syndrome treatment. Comment?
Four star stock poised to pop, Lexicon Pharmaceuticals
... ahead of schedule in a Phase 2a clinical trial of its drug candidate for non-constipating irritable bowel syndrome (IBS), LX1031 , an inhibitor of tryptophan hydroxylase that acts locally in the gastrointestinal tract.A Top-line data from the trial ... Comment?
... lender you're worthy. Here's how to boost your point total. Full Story Though stress does not cause irritable bowel syndrome, it can trigger or intensify your symptoms. Learn more to help manage your IBS. Full Story You've heard of certain foods ... Comment?
Do You Have Money In Your FSA?
Flexible spending accounts are a great way to save a little money on doctor's fees, prescription co-pays, and hospital bills. Comment?
Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
... trials of linaclotide for chronic constipation. The drug, which is in two more pivotal trials for irritable bowel syndrome, has attracted partnering deals with Forest Laboratories for in the U.S. and Laboratorios Almirall in Europe. Analysts predict ... Comment?
How to get more accurate diagnoses.
... ask if it's possible that you have more than one thing wrong with you - migraines, say, along with irritable bowel syndrome. In addition, suggests Dr. Howard Blumstein, a rheumatologist with a practice in Smithtown and Port Jefferson Station, you ... Comment?
IPO Watch: Ironwood, Fabrinet Plan Deals
... offering of up to $172.5 million in stock. The company is developing linaclotide, a treatment for irritable bowel syndrome, and will use proceeds from the offering to fund the drug, as well as other projects. Ironwood plans to trade under the ticker ... Comment?
How to get more accurate medical diagnoses
... ask if it's possible that you have more than one thing wrong with you - migraines, say, along with irritable bowel syndrome. In addition, suggests Dr. Howard Blumstein, a rheumatologist with a practice in Smithtown and Port Jefferson Station, you ... Comment?
How to get the right diagnosis
... ask if it's possible that you have more than one thing wrong with you - migraines, say, along with irritable bowel syndrome. 3. Verify any shocking medical test results. About 3 to 5 percent of the time, something goes wrong with a lab test - a vial ... Comment?
Probiotics' Role in IBS Debated
International gastroenterology and microbiology experts were invited by Institut Rosell-Lallemand to share and discuss with representatives from the pharma and health care industry the latest research on probiotics in irritable bowel syndrome ahead of the UEGW/Gastro 2009 conference. Comment?
Valeant Pharma begins selling generic IBS drug
Valeant Pharmaceuticals said Monday it began selling a generic version of Librax, a treatment for irritable bowel syndrome drug. Comment?
Ironwood looks to IPO, hopes for $172M
... company has one drug candidate in Phase 3 clinical trials, linaclotide, which is designed to combat irritable bowel syndrome and other gastrointestinal maladies. Ironwood also has a Phase 1 pain-drug candidate and various preclinical programs. ... Comment?
Salix Pharmaceuticals raises $128 million selling shares
... hat afflicts diabetics. The company also is testing one of its existing products to treat a type of irritable bowel syndrome. Salix announced plans for the stock sale last week . Comment?
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in...
23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. , announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome will be presented at GASTRO 2009 in London this week. Comment?